Ophthalmology·Los Angeles, CA

UCLA David Geffen School of Medicine/UCLA Medical Center/UCLA Stein and Doheny Eye Institutes

Applicants have reported 2026-27 ophthalmology interview invites from UCLA David Geffen School of Medicine/UCLA Medical Center/UCLA Stein and Doheny Eye Institutes on Oct 13. As of . Every ophthalmology program that has sent

Signal lift5%56%+51 pp with a signal here
Allocate signal →Track an away here24-25 cycle · program-reported
Step 2 invited
-
p10 – p90
Interviewed
50
interviewed (latest year)
This cycle
-
no tracked aways yet
Match rate
16.0%
8 of 50 interviewed
01Cohort funnel24-25 cycle · program-reported
N = 50 interviewed
Interviewed
50
100.0%
Class size
8
16%
J-1 visaAny graduation yearResearch
Your fitUCLA David Geffen School of Medicine/UCLA Medical Center/UCLA Stein and Doheny Eye Institutes Program

Create a free profile to see your personalized fit

Get started
Applicant profile2025 data

What successful applicants at this program look like.

See how competitive you are here

Compare your stats against applicants at UCLA David Geffen School of Medicine

Create free account

Who to contact

Interview day

From notes past applicants shared, 2023-24

The day
Nine 10-minute interviews with one or two faculty
2023-24
What stood out
Strong teaching 2
Concerns raised
Culture concern 5
Worth knowing
  • Residents are unionized, with meal stipends at every site and rides home after call. 2023-24
  • Residents cover one site at a time on call. 2023-24
  • Weekly wet labs and a shortened Wednesday clinic support BCSC study. 2023-24
  • PGY-1s get weekly ophthalmology didactics for 6 months. 2023-24

Paraphrased from applicant notes. A tag shows once two notes mention it; the number is how many did.

Training sites6 hospitals
  • 1
    UCLA David Geffen School of Medicine/UCLA Medical Center
    Los Angeles, CA
    Primary
  • 2
    Olive View/UCLA Medical Center
    Sylmar, CA
    Participant
  • 3
    Los Angeles County-Harbor-UCLA Medical Center
    Torrance, CA
    Participant
  • 4
    Santa Monica-UCLA Medical Center
    Santa Monica, CA
    Participant
  • 5
    Ronald Reagan UCLA Medical Center
    Los Angeles, CA
    Participant
  • 6
    VA Greater Los Angeles Healthcare System
    Los Angeles, CA
    Participant
Interview invites
Loading...
Rotator reports4 reports · paraphrased
mixed hands-on
  • 25-26Rotators recommended the county-site rotations for greater autonomy.
  • 24-25Rotators described the Doheny rotation as attending-focused with no residents. Hands-on exposure varied by attending; rotators suggested setting expectations on day one. OR time was described as limited. Doheny attendings were described as relaxed.
  • 23-24Rotators agreed with prior-year reports: attendings extended autonomy in proportion to what the student demonstrated they could handle.
  • 22-23Rotators described a 3-week rotation in the student's chosen subspecialty at Stein with little infrastructure for aways. Experience was described as heavily dependent on the attending. Reports from current residents described county clinic rotations (Harbor, Olive View) as substantially more hands-on.

Paraphrased from rotator survey responses. Names and identifying details removed.

Score rangesinvited cohort

Step 2 CK data not available

Level 2 CE data not available

Interview rates

No interview data yet

Interview prepOphthalmology
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common
Save this program

Add UCLA David Geffen School of Medicine/UCLA Medical Center/UCLA Stein and Doheny Eye Institutes to your list

Build a personal match list. Compare programs side-by-side, see how your timing stacks against peers, and get notified when peers hear back.

Next

Calculate your match probability for Ophthalmology.

See how your profile compares across all programs.

Open calculator →

Program data, 2025 release. Not medical advice. © 2026 Rezumab LLC.